{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:56:39Z","timestamp":1792252599153,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05368-9","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:06:24Z","timestamp":1743188784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Machine learning in lymphocyte and immune biomarker analysis for childhood thyroid diseases in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Ruizhe","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenTao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"2","key":"5368_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1478-3231.2005.01089.x","volume":"25","author":"F Doi","year":"2005","unstructured":"Doi F, et al. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Liver Int. 2005;25(2):242\u20136.","journal-title":"Liver Int"},{"issue":"7","key":"5368_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2012.0514","volume":"23","author":"AB Glick","year":"2013","unstructured":"Glick AB, et al. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid. 2013;23(7):871\u20138.","journal-title":"Thyroid"},{"issue":"5","key":"5368_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301\u201316.","journal-title":"Nat Rev Endocrinol"},{"key":"5368_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13044-018-0046-9","volume":"11","author":"M Rydzewska","year":"2018","unstructured":"Rydzewska M, et al. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 2018;11:2.","journal-title":"Thyroid Res"},{"issue":"2","key":"5368_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, et al. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174\u201380.","journal-title":"Autoimmun Rev"},{"issue":"1\u20133","key":"5368_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12026-012-8312-8","volume":"54","author":"SA Morshed","year":"2012","unstructured":"Morshed SA, Latif R, Davies TF. Delineating the autoimmune mechanisms in Graves\u2019 disease. Immunol Res. 2012;54(1\u20133):191\u2013203.","journal-title":"Immunol Res"},{"issue":"Suppl 2","key":"5368_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/2047-783X-15-S2-72","volume":"15","author":"AM Kucharska","year":"2010","unstructured":"Kucharska AM, et al. Decreased CD4 + CD152 + T cell subset and its correlation with the level of antithyroid antibodies in children with chronic autoimmune thyroiditis. Eur J Med Res. 2010;15(Suppl 2):72\u20135.","journal-title":"Eur J Med Res"},{"issue":"8","key":"5368_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.endonu.2016.04.003","volume":"63","author":"AM Ramos-Lev\u00ed","year":"2016","unstructured":"Ramos-Lev\u00ed AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr. 2016;63(8):421\u20139.","journal-title":"Endocrinol Nutr"},{"issue":"7","key":"5368_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1056\/NEJM199402173300704","volume":"330","author":"TP Foley Jr","year":"1994","unstructured":"Foley TP Jr., et al. Brief report: hypothyroidism caused by chronic autoimmune thyroiditis in very young infants. N Engl J Med. 1994;330(7):466\u20138.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"5368_CR10","first-page":"45","volume":"5","author":"RS Brown","year":"2013","unstructured":"Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):45\u20139.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"5368_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/CCO.0000000000000150","volume":"27","author":"SI Noureldine","year":"2015","unstructured":"Noureldine SI, Tufano RP. Association of Hashimoto\u2019s thyroiditis and thyroid cancer. Curr Opin Oncol. 2015;27(1):21\u20135.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"5368_CR12","first-page":"888","volume":"138","author":"R Radhakrishnan","year":"2013","unstructured":"Radhakrishnan R, et al. Thyroid dysfunction in major psychiatric disorders in a hospital based sample. Indian J Med Res. 2013;138(6):888\u201393.","journal-title":"Indian J Med Res"},{"key":"5368_CR13","doi-asserted-by":"crossref","unstructured":"Ho CW et al. Increased risk of polycystic ovary syndrome and it\u2019s comorbidities in women with autoimmune thyroid disease. Int J Environ Res Public Health, 2020. 17(7).","DOI":"10.3390\/ijerph17072422"},{"issue":"6","key":"5368_CR14","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.euroneuro.2018.03.011","volume":"28","author":"G Fugger","year":"2018","unstructured":"Fugger G, et al. Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the study of resistant depression (GSRD). Eur Neuropsychopharmacol. 2018;28(6):752\u201360.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"5368_CR15","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamapediatrics.2016.0486","volume":"170","author":"P Hanley","year":"2016","unstructured":"Hanley P, Lord K, Bauer AJ. Thyroid disorders in Children and adolescents: a review. JAMA Pediatr. 2016;170(10):1008\u201319.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"5368_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5455\/medarh.2017.71.62-65","volume":"71","author":"E Hasanbegovic","year":"2017","unstructured":"Hasanbegovic E, Hasanbegovic S, Begic E. Hypothyroidism in Pediatric Population - Bosnian and Herzegovinian Situation. Med Arch. 2017;71(1):62\u20135.","journal-title":"Med Arch"},{"issue":"1","key":"5368_CR17","doi-asserted-by":"publisher","first-page":"103626","DOI":"10.1016\/j.isci.2021.103626","volume":"25","author":"ZC Stensland","year":"2022","unstructured":"Stensland ZC, et al. Peripheral immunophenotyping of AITD subjects reveals alterations in immune cells in pediatric vs adult-onset AITD. iScience. 2022;25(1):103626.","journal-title":"iScience"},{"issue":"2","key":"5368_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1744-313X.2009.00830.x","volume":"36","author":"H Hadj-Kacem","year":"2009","unstructured":"Hadj-Kacem H, et al. Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. Int J Immunogenet. 2009;36(2):85\u201396.","journal-title":"Int J Immunogenet"},{"issue":"8","key":"5368_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ncpendmet0896","volume":"4","author":"LH Duntas","year":"2008","unstructured":"Duntas LH. Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab. 2008;4(8):454\u201360.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"5368_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","volume":"38","author":"M Marin\u00f2","year":"2015","unstructured":"Marin\u00f2 M, et al. Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease. J Endocrinol Invest. 2015;38(3):283\u201394.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"5368_CR21","first-page":"930","volume":"86","author":"TH Brix","year":"2001","unstructured":"Brix TH, et al. Evidence for a major role of heredity in Graves\u2019 disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86(2):930\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5368_CR22","first-page":"1700","volume":"77","author":"L Chiovato","year":"1993","unstructured":"Chiovato L, et al. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab. 1993;77(6):1700\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"5368_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fendo.2020.00406","volume":"11","author":"D Gallo","year":"2020","unstructured":"Gallo D, et al. Immunological drivers in Graves\u2019 Disease: NK cells as a Master Switcher. Front Endocrinol (Lausanne). 2020;11:406.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"5368_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/PCC.0000000000000750","volume":"17","author":"LN Sanchez-Pinto","year":"2016","unstructured":"Sanchez-Pinto LN, Khemani RG. Development of a prediction model of early acute kidney Injury in Critically Ill Children Using Electronic Health Record Data. Pediatr Crit Care Med. 2016;17(6):508\u201315.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"5368_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/pr.2017.116","volume":"82","author":"L Wang","year":"2017","unstructured":"Wang L, et al. Electronic health record-based predictive models for acute kidney injury screening in pediatric inpatients. Pediatr Res. 2017;82(3):465\u201373.","journal-title":"Pediatr Res"},{"issue":"1","key":"5368_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13054-021-03724-0","volume":"25","author":"J Dong","year":"2021","unstructured":"Dong J, et al. Machine learning model for early prediction of acute kidney injury (AKI) in pediatric critical care. Crit Care. 2021;25(1):288.","journal-title":"Crit Care"},{"key":"5368_CR27","doi-asserted-by":"publisher","first-page":"102409","DOI":"10.1016\/j.eclinm.2023.102409","volume":"68","author":"J Hu","year":"2024","unstructured":"Hu J, et al. Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study. EClinicalMedicine. 2024;68:102409.","journal-title":"EClinicalMedicine"},{"issue":"11","key":"5368_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1515\/jpem-2020-0158","volume":"33","author":"T Chen","year":"2020","unstructured":"Chen T, et al. Clinical relevance of T lymphocyte subsets in pediatric Graves\u2019 disease. J Pediatr Endocrinol Metab. 2020;33(11):1425\u201330.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"5368_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/cei.12183","volume":"174","author":"K n der Weerd","year":"2013","unstructured":"n der Weerd K, et al. The peripheral blood compartment in patients with Graves\u2019 disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes. Clin Exp Immunol. 2013;174(2):256\u201364.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"5368_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12020-015-0759-7","volume":"52","author":"R Gonz\u00e1lez-Amaro","year":"2016","unstructured":"Gonz\u00e1lez-Amaro R, Marazuela M. T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine. 2016;52(1):30\u20138.","journal-title":"Endocrine"},{"issue":"9","key":"5368_CR31","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"Marazuela M, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91(9):3639\u201346.","journal-title":"J Clin Endocrinol Metab"},{"key":"5368_CR32","first-page":"39","volume":"380","author":"MG Roncarolo","year":"2014","unstructured":"Roncarolo MG, et al. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol. 2014;380:39\u201368.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"5368_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3109\/08916934.2010.548839","volume":"44","author":"M Nakahara","year":"2011","unstructured":"Nakahara M, et al. The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages. Autoimmunity. 2011;44(6):504\u201310.","journal-title":"Autoimmunity"},{"issue":"3","key":"5368_CR34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4049\/jimmunol.171.3.1216","volume":"171","author":"DJ Kasprowicz","year":"2003","unstructured":"Kasprowicz DJ, et al. Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4 + T cell effector function. J Immunol. 2003;171(3):1216\u201323.","journal-title":"J Immunol"},{"issue":"3","key":"5368_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/08916934.2012.751981","volume":"46","author":"A Bossowski","year":"2013","unstructured":"Bossowski A, et al. Lower proportions of CD4 + CD25(high) and CD4 + FoxP3, but not CD4 + CD25 + CD127(low) FoxP3 + T cell levels in children with autoimmune thyroid diseases. Autoimmunity. 2013;46(3):222\u201330.","journal-title":"Autoimmunity"},{"issue":"9","key":"5368_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","volume":"10","author":"M Miyara","year":"2014","unstructured":"Miyara M, Ito Y, Sakaguchi S. TREG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol. 2014;10(9):543\u201351.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5368_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.coi.2009.05.021","volume":"21","author":"YK Lee","year":"2009","unstructured":"Lee YK, et al. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009;21(3):274\u201380.","journal-title":"Curr Opin Immunol"},{"key":"5368_CR38","doi-asserted-by":"publisher","first-page":"p8431838","DOI":"10.1155\/2017\/8431838","volume":"2017","author":"J Qin","year":"2017","unstructured":"Qin J, et al. Increased circulating Th17 but decreased CD4(+)Foxp3(+) Treg and CD19(+)CD1d(hi)CD5(+) Breg subsets in New-Onset Graves\u2019 Disease. Biomed Res Int. 2017;2017:p8431838.","journal-title":"Biomed Res Int"},{"issue":"1\u20132","key":"5368_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000452541","volume":"40","author":"C Li","year":"2016","unstructured":"Li C, et al. Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases. Cell Physiol Biochem. 2016;40(1\u20132):245\u201352.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"5368_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/08916934.2013.879862","volume":"47","author":"M Klatka","year":"2014","unstructured":"Klatka M, et al. Th17 and Treg cells in adolescents with Graves\u2019 disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity. 2014;47(3):201\u201311.","journal-title":"Autoimmunity"},{"key":"5368_CR41","doi-asserted-by":"publisher","first-page":"979167","DOI":"10.1155\/2015\/979167","volume":"2015","author":"A Pyzik","year":"2015","unstructured":"Pyzik A, et al. Immune disorders in Hashimoto\u2019s thyroiditis: what do we know so far? J Immunol Res. 2015;2015:979167.","journal-title":"J Immunol Res"},{"issue":"2","key":"5368_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3803\/EnM.2019.34.2.132","volume":"34","author":"EK Lee","year":"2019","unstructured":"Lee EK, Sunwoo JB. Natural killer cells and thyroid diseases. Endocrinol Metab (Seoul). 2019;34(2):132\u20137.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"5368_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1398-9995.1989.tb04186.x","volume":"44","author":"BK Pedersen","year":"1989","unstructured":"Pedersen BK, et al. Characterization of the natural killer cell activity in Hashimoto\u2019s and Graves\u2019 diseases. Allergy. 1989;44(7):477\u201381.","journal-title":"Allergy"},{"issue":"11","key":"5368_CR44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/thy.1998.8.1019","volume":"8","author":"BE Wenzel","year":"1998","unstructured":"Wenzel BE, et al. Natural killer cell activity in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Thyroid. 1998;8(11):1019\u201322.","journal-title":"Thyroid"},{"issue":"2","key":"5368_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1172\/JCI112826","volume":"79","author":"M Papic","year":"1987","unstructured":"Papic M, et al. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest. 1987;79(2):404\u20138.","journal-title":"J Clin Invest"},{"issue":"2","key":"5368_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12020-013-9988-9","volume":"45","author":"ST Kawashima","year":"2014","unstructured":"Kawashima ST, et al. Serum levels of IgG and IgG4 in Hashimoto thyroiditis. Endocrine. 2014;45(2):236\u201343.","journal-title":"Endocrine"},{"issue":"3","key":"5368_CR47","first-page":"210","volume":"146","author":"E Potlukov\u00e1","year":"2007","unstructured":"Potlukov\u00e1 E, Limanov\u00e1 Z. [The role of complement in autoimmune thyroid disorders]. Cas Lek Cesk. 2007;146(3):210\u20134.","journal-title":"Cas Lek Cesk"},{"issue":"2","key":"5368_CR48","first-page":"319","volume":"77","author":"G Tuli","year":"2022","unstructured":"Tuli G, et al. Lymphocyte population in peripheral blood in children and adolescents with graves disease. Potential Predictive tool Severity Disease Endocr. 2022;77(2):319\u201324.","journal-title":"Potential Predictive tool Severity Disease Endocr"},{"key":"5368_CR49","doi-asserted-by":"publisher","first-page":"m3919","DOI":"10.1136\/bmj.m3919","volume":"371","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar. BMJ. 2020;371:m3919.","journal-title":"BMJ"},{"issue":"9","key":"5368_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905\u201317.","journal-title":"N Engl J Med"},{"issue":"2","key":"5368_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2265.1988.tb03657.x","volume":"28","author":"PW Wang","year":"1988","unstructured":"Wang PW, et al. Depressed natural killer activity in Graves\u2019 disease and during antithyroid medication. Clin Endocrinol (Oxf). 1988;28(2):205\u201314.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1s","key":"5368_CR52","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang X, Cheng Z, Studies C-S. Strengths, weaknesses, and recommendations. Chest. 2020;158(1s):S65\u201371.","journal-title":"Chest"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05368-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:50:48Z","timestamp":1743400248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5368"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05368-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study have received ethics approval by IEC of Children\u2019s Hospital of Nanjing Medical University (Ethics Approval Number: 202403014-1). As this was a retrospective study and all participant data were obtained exclusively from pre-existing electronic medical records, we applied for a waiver of informed consent. This application was approved by the Institutional Ethics Committee (IEC) of Nanjing Medical University Children\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"249"}}